The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Relative Contribution of Insulin and Its Precursors to Fibrinogen and PAI-1 in a Large Population With Different States of Glucose Tolerance: The Insulin Resistance Atherosclerosis Study (IRAS)
Open accessAbstract
Abstract —Hyperinsulinemia is associated with the development of coronary heart disease. However, the underlying mechanisms are still poorly understood. Hypercoagulability and impaired fibrinolysis are possible candidates linking hyperinsulinism with atherosclerotic disease, and it has been suggested that proinsulin rather than insulin is the crucial pathophysiological agent. The aim of this study was to investigate the relationship of insulin and its precursors to markers of coagulation and fibrinolysis in a large triethnic population. A strong and independent relationship between plasminogen activator inhibitor-1 (PAI-1) antigen and insulin and its precursors (proinsulin, 32-33 split proinsulin) was found consistently across varying states of glucose tolerance (PAI-1 versus fasting insulin [proinsulin], r =0.38 [ r =0.34] in normal glucose tolerance; r =0.42 [ r =0.43] in impaired glucose tolerance; and r =0.38 [ r =0.26] in type 2 diabetes; all P <0.001). The relationship remained highly significant even after accounting for insulin sensitivity as measured by a frequently sampled intravenous glucose tolerance test. In a stepwise multiple regression model after adjusting for age, sex, ethnicity, and clinic, both insulin and its precursors were significantly associated with PAI-1 levels. The relationship between fibrinogen and insulin and its precursors was significant in the overall population ( r =0.20 for insulin and proinsulin; each P <0.001) but showed a more inconsistent pattern in subgroup analysis and after adjustments for demographic and metabolic variables. Stepwise multiple regression analysis showed that proinsulin (split products) but not fasting insulin significantly contributed to fibrinogen levels after adjustment for age, sex, clinic, and ethnicity. Decreased insulin sensitivity was independently associated with higher PAI-1 and fibrinogen levels. In summary, we were able to demonstrate an independent relationship of 2 crucial factors of hemostasis, fibrinogen and PAI-1, to insulin and its precursors. These findings may have important clinical implications in the risk assessment and prevention of macrovascular disease, not only in patients with overt diabetes but also in nondiabetic subjects who are hyperinsulinemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (1957) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,208
Coated Charcoal Immunoassay of Insulin
HERBERT, V., LAU, K.-S., GOTTLIEB, C. W., & BLEICHER, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,968
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,646
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X)
Haffner, S. M., Valdez, R. A., Hazuda, H. P., Mitchell, B. D., Morales, P. A., & Stern, M. P. (1992) · Diabetes · doi:10.2337/diab.41.6.715 · Cited by 1,238
Self-citationAssessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Fibrinogen as a Cardiovascular Risk Factor: A Meta-Analysis and Review of the Literature
Ernst, E., & Resch, K. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-12-199306150-00008 · Cited by 990
Zavaroni, I., Bonora, E., Pagliara, M., Dall'Aglio, E., Luchetti, L., Buonanno, G., Bonati, P. A., Bergonzani, M., Gnudi, L., Passeri, M., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201105 · Cited by 771
Insulin Sensitivity and Atherosclerosis
Howard, G., O’Leary, D. H., Zaccaro, D., Haffner, S., Rewers, M., Hamman, R., Selby, J. V., Saad, M. F., Savage, P., & Bergman, R. (1996) · Circulation · doi:10.1161/01.cir.93.10.1809 · Cited by 729
Self-citationHow good a marker is insulin level for insulin resistance?
Laakso, M. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116768 · Cited by 726
Pacini, G., & Bergman, R. N. (1986) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(86)90106-9 · Cited by 695
Insulin and Atheroma: 20-Yr Perspective
Stout, R. W. (1990) · Diabetes Care · doi:10.2337/diacare.13.6.631 · Cited by 571
Juhan-Vague, I., Alessi, M. C., & Vague, P. (1991) · Diabetologia · doi:10.1007/bf00403280 · Cited by 567
The Insulin Resistance Atherosclerosis Study (IRAS)
Wagenknecht, L. E., Mayer, E. J., Rewers, M., Haffner, S., Selby, J., Borok, G. M., Henkin, L., Howard, G., Savage, P. J., Saad, M. F., et al. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(95)00062-3 · Cited by 492
Self-citationVague, P., Juhan-Vague, I., Aillaud, M. F., Badier, C., Viard, R., Alessi, M. C., & Collen, D. (1986) · Metabolism · doi:10.1016/0026-0495(86)90209-x · Cited by 443
Saad, M. F., Anderson, R. L., Laws, A., Watanabe, R. M., Kades, W. W., Chen, Y. D. I., Sands, R. E., Pei, D., Savage, P. J., & Bergman, R. N. (1994) · Diabetes · doi:10.2337/diab.43.9.1114 · Cited by 376
Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience
Kannel, W. B., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., & Gagnon, D. R. (1990) · American Heart Journal · doi:10.1016/0002-8703(90)90026-t · Cited by 368
Self-citationPyörälä, K., Savolainen, E., Kaukola, S., & Haapakoski, J. (1985) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1985.tb08888.x · Cited by 364
Landin, K., Stigendal, L., Eriksson, E., Krotkiewski, M., Risberg, B., Tengborn, L., & Smith, U. (1990) · Metabolism · doi:10.1016/0026-0495(90)90164-8 · Cited by 342
WELCH, S., GEBHART, S. S. P., BERGMAN, R. N., & PHILLIPS, L. S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1508 · Cited by 337
INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES
Temple, R., Luzio, S., Schneider, A., Carrington, C., Owens, D., Sobey, W., & Nicholas Hales, C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91306-8 · Cited by 337
Sobey, W. J., Beer, S. F., Carrington, C. A., Clark, P. M. S., Frank, B. H., Gray, I. P., Luzio, S. D., Owens, D. R., Schneider, A. E., Siddle, K., et al. (1989) · Biochemical Journal · doi:10.1042/bj2600535 · Cited by 336
Self-citationJuhan-Vague, I., Thompson, S. G., & Jespersen, J. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.12.1865 · Cited by 322
Eschwège, É., Richard, J. L., Thibult, N., Ducimetière, P., Warnet, J., Claude, J., & Rosselin, G. (1985) · PubMed · Cited by 311
Factors Responsible for Impaired Fibrinolysis in Obese Subjects and NIDDM Patients
McGill, J. B., Schneider, D. J., Arfken, C. L., Lucore, C. L., & Sobel, B. E. (1994) · Diabetes · doi:10.2337/diab.43.1.104 · Cited by 310
STERN, M. P., ROSENTHAL, M., HAFFNER, S. M., HAZUDA, H. P., & FRANCO, L. J. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113956 · Cited by 308
Self-citationAlessi, M. C., Juhan-Vague, I., Kooistra, T., Declerck, P. J., & Collen, D. (1988) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646997 · Cited by 289
Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics
Haffner, S. M., Fong, D., Hazuda, H. P., Pugh, J. A., & Patterson, J. K. (1988) · Metabolism · doi:10.1016/0026-0495(88)90133-3 · Cited by 254
Self-citationPotter van Loon, B. J., Kluft, C., Radder, J. K., Blankenstein, M. A., & Meinders, A. E. (1993) · Metabolism · doi:10.1016/0026-0495(93)90005-9 · Cited by 225
METHODS AND PREVALENCE OF NON-INSULIN-DEPENDENT DIABETES MELLITUS IN A BIETHNIC COLORADO POPULATION
HAMMAN, R. F., MARSHALL, J. A., BAXTER, J., KAHN, L. B., MAYER, E. J., ORLEANS, M., MURPHY, J. R., & LEZOTT, D. C. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115134 · Cited by 218
Steil, G. M., Volund, A., Kahn, S. E., & Bergman, R. N. (1993) · Diabetes · doi:10.2337/diab.42.2.250 · Cited by 215
Nagi, D. K., Hendra, T. J., Ryle, A. J., Cooper, T. M., Temple, R. C., Clark, P. M. S., Schneider, A. E., Hales, C. N., & Yudkin, J. S. (1990) · Diabetologia · doi:10.1007/bf00404140 · Cited by 198
Self-citationPLASMA INSULIN AND LIPOPROTEIN CONCENTRATIONS: AN ATHEROGENIC ASSOCIATION?
ORCHARD, T. J., BECKER, D. J., BATES, M., KULLER, L. H., & DRASH, A. L. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113639 · Cited by 187
Induction of Plasminogen Activator Inhibitor Type-1 (PAI-1) by Proinsulin and Insulin In Vivo
Nordt, T. K., Sawa, H., Fujii, S., & Sobel, B. E. (1995) · Circulation · doi:10.1161/01.cir.91.3.764 · Cited by 185
Hyperfibrinogenemia: An important risk factor for vascular complications in diabetes
Ganda, O. P., & Arkin, C. F. (1992) · Diabetes Care · doi:10.2337/diacare.15.10.1245 · Cited by 169
Panahloo, A., Mohamed-Ali, V., Lane, A., Green, F., Humphries, S. E., & Yudkin, J. S. (1995) · Diabetes · doi:10.2337/diab.44.1.37 · Cited by 167
Abbott, W. G. H., Lillioja, S., Young, A. A., Zawadzki, J. K., Yki-Järvinen, H., Christin, L., & Howard, B. V. (1987) · Diabetes · doi:10.2337/diab.36.8.897 · Cited by 166
Nordt, T. K., Schneider, D. J., & Sobel, B. E. (1994) · Circulation · doi:10.1161/01.cir.89.1.321 · Cited by 159
Relationship between lipoprotein levels and in vivo insulin action in normal young white men
Garg, A., Helderman, J. H., Koffler, M., Ayuso, R. M. A., Rosenstock, J., & Raskin, P. (1988) · Metabolism · doi:10.1016/0026-0495(88)90157-6 · Cited by 142
Juhan-Vague, I., Alessi, M., & Vague, P. (1996) · Annals of Medicine · doi:10.3109/07853899608999095 · Cited by 142
Schneider, D. J., Nordt, T. K., & Sobel, B. E. (1992) · Diabetes · doi:10.2337/diab.41.7.890 · Cited by 124
Asplund-Carlson, A., Hamsten, A., Wiman, B., & Carlson, L. A. (1993) · Diabetologia · doi:10.1007/bf00400356 · Cited by 120
Henry, M., Trégouët, D., Alessi, M., Aillaud, M. F., Visvikis‐Siest, S., Siest, G., Tiret, L., & Juhan-Vague, I. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.1.84 · Cited by 120
Relationship of Proinsulin and Insulin to Cardiovascular Risk Factors in Nondiabetic Subjects
Haffner, S. M., Mykkänen, L. M., D, M. P. S. M., Valdez, R. A., Heisserman, J. A., & Bowsher, R. R. (1993) · Diabetes · doi:10.2337/diab.42.9.1297 · Cited by 100
Self-citationEliasson, M., Evrin, P., & Lundblad, D. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90298-4 · Cited by 96
Update on fibrinogen as a cardiovascular risk factor
Kannel, W. B., D’Agostino, R. B., & Belanger, A. J. (1992) · Annals of Epidemiology · doi:10.1016/1047-2797(92)90095-8 · Cited by 85
Self-citationKnöbl, P., Schernthaner, G.-H., Schnack, C., Pietschmann, P., Griesmacher, A., Prager, R., & Müller, M. M. (1993) · Diabetologia · doi:10.1007/bf02374497 · Cited by 84
Geffken, D. F., Fg, K., Mh, K., Es, C., BOVILL, E. G., & Tracy, R. P. (1994) · PubMed · Cited by 58
Self-citationMohamed‐Ali, V., Gould, M., Gillies, S., Goubet, S., Yudkin, J. S., & Haines, A. (1995) · Diabetologia · doi:10.1007/bf00402183 · Cited by 50
Declerck, P. J., & Collen, D. (1990) · Thrombosis Research · doi:10.1016/0049-3848(90)90373-k · Cited by 50
Macy, E. M., Meilahn, E. N., Declerck, P. J., & Tracy, R. P. (1993) · PubMed · Cited by 46
Self-citationPlasma Fibrinogen in NIDDM: The Rotterdam Study
Missov, R. M., Stolk, R. P., van der Bom, J. G., Albert Hofman, D., Bots, M. L., Pols, H. A. P., & Grobbee, D. E. (1996) · Diabetes Care · doi:10.2337/diacare.19.2.157 · Cited by 42
Gray, R. P. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06070-4 · Cited by 41
Ostrega, D., Polonsky, K. S., Nagi, D. K., Yudkin, J. S., Cox, L., CLARK, P. M. S., & Hales, C. N. (1995) · Diabetes · doi:10.2337/diab.44.4.437 · Cited by 33
Self-citationNagi, D. K., Knowler, W. C., Hanson, R. L., Mohamed‐Ali, V., & Yudkin, J. S. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650395 · Cited by 16
Cited by
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,378
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Self-citationFesta, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Self-citationThe relation of body fat mass and distribution to markers of chronic inflammation
Festa, A., D'Agostino Jr, R., Williams, K., Karter, A., Mayer-Davis, E., Tracy, R., & Haffner, S. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801792 · Cited by 706
Self-citationPlatelet Dysfunction in Type 2 Diabetes
Vinik, A. I., Erbas, T., Park, T. S., Nolan, R., & Pittenger, G. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1476 · Cited by 671
Metadata
- Authors
- Festa, A., D’Agostino, R., Mykkänen, L., Tracy, R. P., Zaccaro, D. J., Hales, C. N., & Haffner, S. M.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1999-03
- Volume
- 19
- Issue
- 3
- Pages
- 562-568
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2035498702
- Cited by
- 263
- References
- 59
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.